| ||||||||||||||||||||||||||
|
Takayasu's Arteritis What is arteritis?
What is Takayasu's arteritis? Less commonly, arteries that provide blood flow to the heart, intestines, kidneys and legs may be involved. Inflammation of large blood vessels may cause segments of the vessels to weaken and stretch, resulting in an aneurysm. Vessels can also become narrowed or even completely blocked (called an occlusion). What are the symptoms? The changes that occur in TA are often gradual, allowing alternate (or collateral) routes of blood flow to develop. These alternate routes are often smaller "side roads." The collateral vessels may or may not be adequate to carry as much blood as was present normally. In general, the blood flow that occurs beyond an area of narrowing is almost always adequate to allow tissues to survive. In rare cases, if collateral blood vessels are not available in sufficient quantity, the tissue that is no longer supplied by blood and oxygen will die. This is called an "infarction." Narrowing of blood vessels to the arms or legs may cause fatigue, pain, or aching due to reduced blood supply -- especially during activities such as shampooing the hair, exercising or walking. It is much less common for decreased blood flow to cause a stroke or a heart attack (myocardial infarction). In some patients, decreased blood flow to the intestines may lead to abdominal pain, especially after meals. Decreased blood flow to the kidneys may cause high blood pressure, but rarely causes kidney failure. Some patients with TA may not have any symptoms. Their diagnosis may be stumbled upon by a doctor who has difficulty measuring blood pressure in one or both arms. Similarly, a doctor may notice that the strength of pulses in the wrists, neck or groin may not be equal, or the pulse on one side may be absent. What causes TA? Who is affected by TA? Every year in the United States, two to three new cases of TA per million Americans are diagnosed. How is TA diagnosed?
Note: With most other forms of vasculitis, a biopsy (tissue sample) of the affected area confirms the presence of blood vessel inflammation. A biopsy is most appropriate when easily accessible areas, such as the skin, are affected. However, when large blood vessels are affected, a biopsy is often not practical because of the risks of surgery. How is TA treated? The goal of therapy is to stop all damage due to vasculitis. Once it is apparent that the disease is under control, doctors slowly reduce the dose of prednisone to sustain improvement, thereby trying to minimize treatment side effects. In some patients, it is possible to gradually discontinue medication without a relapse. As the dose of prednisone is gradually reduced, about half of all patients will have recurrent symptoms or progression of illness. This has led to exploring additional therapies to produce remission. Among medications that have been tried, with varying degrees of success, are "chemotherapy" medications such as cyclophosphamide (Cytoxan®) and methotrexate (Rheumatrex®). When these medications are added to prednisone to treat TA, 50 percent of patients who had previously relapsed will achieve remission and be able to gradually discontinue prednisone. Overall, about 25 percent of patients will have disease that is not entirely controlled without continued use of these therapies. This emphasizes the need for continuing research to identify better and less toxic treatments for TA and other forms of vasculitis. Many patients with TA have high blood pressure (hypertension). Careful control of blood pressure is very important. Inadequate treatment of high blood pressure may result in stroke, heart disease, or kidney failure. In some instances, narrowing of arteries to the kidney may be the cause of hypertension. Whenever possible, it is desirable to stretch narrow vessel openings with a balloon (angioplasty) or to do a bypass operation to restore normal flow to the kidney. This may result in normal blood pressure, without the need to use antihypertensive medications. Some patients may have serious disabilities because of narrowed blood vessels to other sites such as the arms or legs. Bypass operations may correct these abnormalities. Aneurysms can also be surgically repaired or corrected. What is the outlook? For patients who live long lives, in spite of having Takayasu's disease, there are significant problems that must be recognized. Having a chronic illness requires periodic evaluation and adjustment of medications whenever necessary. The medications for TA have side effects, and these must be monitored by a physician, as well as by blood tests. The effects of illness on function may be significant. In our experience, 25 percent of patients have an entirely normal lifestyle. Another 25 percent have had to make some adjustments in their activities. About half of our patients had to modify their jobs and a small number of that group were occupationally disabled. TA is clearly a treatable disease, and most patients improve. However, it is apparent that many patients have to deal with consequences of this illness that may be partially, or less often, completely disabling. These effects can be minimized by a team of physicians that includes specialists in vascular and immunologic diseases (rheumatology, immunology, radiology, vascular medicine, vascular and cardiac surgery). For best results, a team leader should coordinate diagnostic tests and the different forms of treatment that TA patients may require. ©Copyright 1995-2007 The Cleveland Clinic Foundation. All rights reserved
index#7097 | ||||||||||||||||||||||||||